Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Enliven Therapeutics, Inc.
Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update
November 5, 2026
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
October 14, 2026
Enliven Therapeutics to Present at Upcoming Investor Conferences
September 3, 2026
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
August 31, 2026